Unlock instant, AI-driven research and patent intelligence for your innovation.

Novel Renin Inhibitors

A halogen and group technology, applied in the field of new compounds, can solve the problem of not involving the details of morpholine compounds, and achieve the effect of excellent renin inhibition

Active Publication Date: 2019-10-15
SHANGAI PHARMA GRP CO LTD +1
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, no details about morpholine compounds are mentioned in this published patent

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel Renin Inhibitors
  • Novel Renin Inhibitors
  • Novel Renin Inhibitors

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0286] [Chemical formula 5]

[0287]

[0288] (1) Add (3-{3-[(1R)-1-(cyclopropylamino)ethyl]-6-methyl-1H-pyrazolo[3,4-b]pyridine- 1-yl}propyl)carbamate (4.00g), and (2R,6S)-4-(tert-butoxycarbonyl)-6-(methoxymethyl)morpholine-2-carboxylic acid (3.66 g) g) To a solution of N,N-dimethylformamide (80 mL), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (3.45 g), 1-hydroxyl Benzotriazole (1.63 g) was then stirred at room temperature for 5 hours. To the reaction mixture was added saturated aqueous sodium bicarbonate solution, followed by extraction with ethyl acetate. The organic phase was washed with water and saturated brine in this order, dried over sodium sulfate, and then concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (eluent: n-hexane / ethyl acetate=1 / 1→ethyl acetate) to obtain (2R,6S)-2-{cyclopropyl[(1R) )-1-(1-{3-[(methoxycarbonyl)amino]propyl}-6-methyl-1H-pyrazolo[3,4-b]pyridin-3-yl)ethyl]aminomet...

Embodiment 2

[0293] [Chemical formula 6]

[0294]

[0295] (1) To (2R,6S)-4-(tert-butoxycarbonyl)-6-(methoxymethyl)morpholine-2-carboxylic acid (7.59 g) in dichloromethane (70 mL) under ice-cooling To the solution, diisopropylethylamine (9.60 mL) and diphenyl chlorophosphate (5.71 mL) were added, followed by stirring under ice-cooling for 15 minutes. Under ice-cooling, methyl (3-{4-[(1R)-1-(cyclopropylamino)ethyl]-6-methoxypyridin-2-yl}propyl)carbamate (5.65 g) was added dropwise. ) in dichloromethane (20 mL), and then stirred at room temperature for 20 hours. Under ice-cooling, a saturated aqueous sodium hydrogencarbonate solution was added to the reaction mixture, followed by extraction with chloroform. The organic phase was washed with saturated brine, dried over sodium sulfate, and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (eluent: n-hexane / ethyl acetate=1 / 1→ethyl acetate) to obtain (2R,6S)-2-{cyclopropyl[(1R) )-1-...

Embodiment 3

[0300] [Chemical formula 7]

[0301]

[0302] (1) Under nitrogen flow and ice cooling, to a dichloromethane solution (20 mL) of (2R,6S)-4-(tert-butoxycarbonyl)-6-(methoxycarbonyl)morpholine-2-carboxylic acid (289 mg) ), diisopropylamine (523 μL) and diphenyl chlorophosphate (415 μL) were added, followed by stirring under ice cooling for 30 minutes, after which (3-{2-bromo-5-[(1R)-1-(cyclohexane) was added A solution of methyl propylamino)ethyl]thiophen-3-yl}propyl)carbamate (361 mg) in dichloromethane (3 mL) was stirred at room temperature for 4 hours. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, followed by extraction with chloroform. The organic phase was washed with saturated brine, dried over anhydrous magnesium sulfate, and the solvent was removed under reduced pressure. The obtained residue was purified by silica gel column chromatography (eluent: n-hexane / ethyl acetate=75 / 25→40 / 60) to obtain (2S,6R)-6-{[(1R)-1 -(5-Bromo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a nitrogen-containing saturated heterocyclic compound effective as a renin inhibitor. A compound or a pharmacologically acceptable salt thereof, wherein the compound is represented by the following formula [I], wherein, R 1 Represents a cycloalkane group or an alkane group, R 22 Represents an aryl group that may be substituted, R represents a lower alkane group, R 3 , R 4 , R 5 and R 6 are the same or different, and represent a hydrogen atom, an optionally substituted carbamoyl group, an optionally substituted alkane group, or an alkoxycarbonyl group.

Description

technical field [0001] The present invention relates to a medicine, in particular to a novel compound effective as a renin inhibitor or a pharmacologically acceptable salt thereof and its use, preparation method or intermediate. Background technique [0002] Development of a renin inhibitor is expected to be used as a drug for the prevention or treatment of hypertension, heart failure, diabetic nephropathy, etc., and for example, 3,4-substituted piperidine compounds are disclosed (Patent Document 1). However, no details about morpholine compounds are mentioned in this publication. [0003] In addition, although morpholine compounds are disclosed in International Publication No. 2008 / 153182, only compounds in which R in the general formula I of the invention of the present application is hydrogen are disclosed (Patent Document 2). [0004] prior art literature [0005] patent documents [0006] Patent Document 1: International Publication No. 06 / 069788 (US Publication No. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D265/30A61K31/5377A61P9/04A61P9/12A61P13/12A61P43/00C07D413/12C07D413/14C07D417/12C07D471/04C07D487/04C07D491/048
CPCC07D265/30C07D413/12C07D413/14C07D417/12C07D471/04C07D487/04C07D491/048A61P9/04A61P9/12A61P13/10A61P13/12A61P43/00C07D417/14
Inventor 饭嶋彻高桥阳一平井未希须釜宽富樫优子沈竞康夏广新万惠新
Owner SHANGAI PHARMA GRP CO LTD